Showing 61 to 72 of 152 results
Trump Executive Order Targets High US Prescription Drug Prices
President Trump signed an executive order on Monday aiming to slash US prescription drug prices by up to 90 percent, blaming foreign countries for the price disparity while the pharmaceutical industry and Senator Sanders disagree on the root cause.
Trump Executive Order Targets High US Prescription Drug Prices
President Trump signed an executive order on Monday aiming to slash US prescription drug prices by up to 90 percent, blaming foreign countries for the price disparity while the pharmaceutical industry and Senator Sanders disagree on the root cause.
Progress
56% Bias Score
Trump Executive Order Aims to Slash Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices in the U.S. by referencing prices in other developed countries, potentially reducing costs by 50-90% for some drugs; however, full implementation requires further rule-making by government agencies.
Trump Executive Order Aims to Slash Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices in the U.S. by referencing prices in other developed countries, potentially reducing costs by 50-90% for some drugs; however, full implementation requires further rule-making by government agencies.
Progress
40% Bias Score
Trump's Executive Order Targets High Prescription Drug Prices
President Trump signed an executive order on May 12th aiming to lower U.S. prescription drug prices by tying them to the lowest prices in comparable developed countries, potentially saving Americans 50-90% on medication costs, but facing legal and implementation challenges and risking drug shortages...
Trump's Executive Order Targets High Prescription Drug Prices
President Trump signed an executive order on May 12th aiming to lower U.S. prescription drug prices by tying them to the lowest prices in comparable developed countries, potentially saving Americans 50-90% on medication costs, but facing legal and implementation challenges and risking drug shortages...
Progress
40% Bias Score
Trump's Plan to Lower US Drug Prices: Aimed at Europe
US President Donald Trump announced a plan to lower American drug prices by matching the lowest rates in other wealthy countries, potentially saving billions of dollars annually, while criticizing European drug pricing negotiations as "difficult, brutal, and nasty.
Trump's Plan to Lower US Drug Prices: Aimed at Europe
US President Donald Trump announced a plan to lower American drug prices by matching the lowest rates in other wealthy countries, potentially saving billions of dollars annually, while criticizing European drug pricing negotiations as "difficult, brutal, and nasty.
Progress
52% Bias Score
Trump's New Executive Order Targets High Medicare Drug Costs
President Trump announced a new executive order to lower Medicare Part B drug costs by matching them to the lowest prices paid by other countries, potentially saving billions of dollars but facing strong industry opposition and legal challenges.
Trump's New Executive Order Targets High Medicare Drug Costs
President Trump announced a new executive order to lower Medicare Part B drug costs by matching them to the lowest prices paid by other countries, potentially saving billions of dollars but facing strong industry opposition and legal challenges.
Progress
52% Bias Score
Novo Nordisk Cuts Forecasts Amid Copycat Weight-Loss Drug Surge
Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, cut its sales and profit forecasts due to competition from copycat weight-loss drugs made by compounding pharmacies in the US, which captured about a third of the market despite a forthcoming ban and the company exceeding first...
Novo Nordisk Cuts Forecasts Amid Copycat Weight-Loss Drug Surge
Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, cut its sales and profit forecasts due to competition from copycat weight-loss drugs made by compounding pharmacies in the US, which captured about a third of the market despite a forthcoming ban and the company exceeding first...
Progress
40% Bias Score
Trump's Executive Order Targets High US Drug Prices
President Trump issued a new executive order aiming to lower US drug prices by aligning them with those in Europe and the UK, impacting millions of Americans, particularly seniors on Medicare Part B; the policy's success depends on Congressional approval and potential legal challenges.
Trump's Executive Order Targets High US Drug Prices
President Trump issued a new executive order aiming to lower US drug prices by aligning them with those in Europe and the UK, impacting millions of Americans, particularly seniors on Medicare Part B; the policy's success depends on Congressional approval and potential legal challenges.
Progress
48% Bias Score
Trump's Executive Order Targets High US Prescription Drug Prices
President Trump issued an executive order aiming to slash US prescription drug prices by at least 59 percent, accusing Germany and the EU of contributing to high costs by forcing lower prices in Europe, potentially reviving the "most favored nation" policy to align US Medicare drug prices with inter...
Trump's Executive Order Targets High US Prescription Drug Prices
President Trump issued an executive order aiming to slash US prescription drug prices by at least 59 percent, accusing Germany and the EU of contributing to high costs by forcing lower prices in Europe, potentially reviving the "most favored nation" policy to align US Medicare drug prices with inter...
Progress
56% Bias Score
Trump Orders 59% US Prescription Drug Price Cut, Blames EU
President Trump signed an executive order on Monday mandating at least a 59% reduction in US prescription drug prices within 30 days, blaming high costs on the EU's lower drug pricing policies and threatening Medicare payment restrictions for non-compliance.
Trump Orders 59% US Prescription Drug Price Cut, Blames EU
President Trump signed an executive order on Monday mandating at least a 59% reduction in US prescription drug prices within 30 days, blaming high costs on the EU's lower drug pricing policies and threatening Medicare payment restrictions for non-compliance.
Progress
56% Bias Score
Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Progress
64% Bias Score
Trump to Issue Executive Order Lowering Prescription Drug Prices
President Trump will sign an executive order next week to lower prescription drug prices by implementing a 'most favored nation' pricing model for Medicare, potentially saving billions and impacting millions of Americans while facing significant industry opposition.
Trump to Issue Executive Order Lowering Prescription Drug Prices
President Trump will sign an executive order next week to lower prescription drug prices by implementing a 'most favored nation' pricing model for Medicare, potentially saving billions and impacting millions of Americans while facing significant industry opposition.
Progress
40% Bias Score
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
Progress
52% Bias Score
Showing 61 to 72 of 152 results